| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | UMF554N5FG |
| InChI Key | VAZAPHZUAVEOMC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H15N3O2 |
| Molecular Weight | 269.3 |
| AlogP | 2.48 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 84.22 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 20.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Histone deacetylase inhibitor | PubMed |
| Primary Target | |
|---|---|
| histone deacetylase 1 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
3810 | 41-18220 | - | 190 | 42-81 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIa
|
3810 | 1810-6000 | - | - | 42-81 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
3810 | 1810-6000 | - | - | 42-81 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IV
|
3810 | 1810-6000 | - | - | 42-81 | |
|
Unclassified protein
|
- | 190 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 112522-64-2 |
| ChEBI | 90195 |
| ChEMBL | CHEMBL235191 |
| DrugBank | DB12291 |
| EPA CompTox | DTXSID60150095 |
| FDA SRS | UMF554N5FG |
| Guide to Pharmacology | 8367 |
| PubChem | 2746 |
| SureChEMBL | SCHEMBL144794 |
| ZINC | ZINC000000003803 |